普门科技(688389)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688389 普门科技

午间休市 06-22 11:29:40

{"stockData":{"symbol":"688389","market":"SH","secType":"STK","nameCN":"普门科技","latestPrice":10.2,"timestamp":1782098980000,"preClose":10.49,"halted":0,"volume":1713191,"delay":0,"changeRate":-0.0276,"floatShares":428000000,"shares":428000000,"eps":0.3805,"marketStatus":"午间休市","change":-0.29,"latestTime":"06-22 11:29:40","open":10.5,"high":10.5,"low":10.06,"amount":17429300,"amplitude":0.0419,"askPrice":10.2,"askSize":54,"bidPrice":10.18,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.3805,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782104400000},"marketStatusCode":3,"adr":0,"adjPreClose":10.49,"symbolType":"stock_kcb","openAndCloseTimeList":[[1782091800000,1782099000000],[1782104400000,1782111600000]],"highLimit":11.54,"lowLimit":9.44,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":428485730,"isCdr":false,"pbRate":2.09,"roa":"--","peRate":26.806833,"roe":"1.52%","epsLYR":0.43,"committee":0.044335,"marketValue":4371000000,"turnoverRate":0.004,"status":1,"floatMarketCap":4371000000},"requestUrl":"/m/hq/s/688389/tweets","defaultTab":"tweets","newsList":[{"id":"2644618704","title":"普门科技：2025年度6项小分子夹心法试剂获注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2644618704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644618704?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:51","pubTimestamp":1781776293,"startTime":"0","endTime":"0","summary":"2025年度，公司雌二醇、游离三碘甲状腺原氨酸、游离甲状腺素、总甲状腺素等6项小分子夹心法电化学发光试剂产品取得医疗器械注册证书，在灵敏度、精密度及抗干扰能力等方面持续优化，进一步提升了公司在性激素及甲状腺功能检测领域的市场竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800031938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644704869","title":"普门科技：公司UA系列全自动特定蛋白分析仪已取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2644704869","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644704869?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:42","pubTimestamp":1781775753,"startTime":"0","endTime":"0","summary":"证券之星消息，普门科技(688389)06月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司U系列特定蛋白分析仪计划何时投放市场？配套的试剂研发进展情况如何？普门科技回复：尊敬的投资者，您好！公司UA系列全自动特定蛋白分析仪已取得医疗器械注册证，感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800031665.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","09996","BK1583","BK1100","688389","BK0251","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644701007","title":"普门科技：已实现电化学发光全系列产品布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2644701007","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644701007?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:42","pubTimestamp":1781775724,"startTime":"0","endTime":"0","summary":"基于电化学发光免疫分析技术平台，在设备方面，已实现低速、中速、高速及流水线的全系列产品布局，可满足不同层级医院及实验室的多样化检测应用需求；在配套试剂研发方面，公司持续丰富试剂项目检测套餐，且基于小分子夹心法技术路线推进试剂项目研发，进一步夯实检测性能；同时，公司持续推进电化学发光试剂产品的国际注册认证进程，为海外市场持续拓展奠定基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800031637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644701548","title":"普门科技：公司高能V拉美产品销售进展比较顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=2644701548","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644701548?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:24","pubTimestamp":1781774666,"startTime":"0","endTime":"0","summary":"证券之星消息，普门科技(688389)06月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司高能V拉美市场销售情况如何？在公立医院入院情况如何？与半岛产品相比有竞争力吗？普门科技回复：您好，公司高能V拉美产品销售进展比较顺利，是国内第二款获得国家药品监督管理局（NMPA）三类医疗器械注册证的聚焦超声抗衰设备，以高能量和深度治疗为核心特色，在公立和民营皮肤医美客户端取得较好的市场口碑和装机进展。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800030404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644701526","title":"普门科技：公司当前生产经营正常有序","url":"https://stock-news.laohu8.com/highlight/detail?id=2644701526","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644701526?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:24","pubTimestamp":1781774659,"startTime":"0","endTime":"0","summary":"证券之星消息，普门科技06月18日在投资者关系平台上答复投资者关心的问题。投资者提问：上证指数重新站上4000点，公司股价却处于上市以来的历史低位。公司当前生产经营正常有序，公司严格遵循信息披露规则，不存在未披露的重大风险与经营隐患。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800030384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644870157","title":"普门科技：公司与快奥森多的合作项目正常推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2644870157","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644870157?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:24","pubTimestamp":1781774658,"startTime":"0","endTime":"0","summary":"证券之星消息，普门科技(688389)06月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问与快奥森多的合作进展目前处在什么阶段？有实质性产品推向市场吗？普门科技回复：尊敬的投资者，您好！公司与快奥森多的合作项目正常推进中。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800030381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644872701","title":"普门科技：锚定体外诊断与治疗康复两条核心赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2644872701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644872701?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:21","pubTimestamp":1781774489,"startTime":"0","endTime":"0","summary":"证券之星消息，普门科技06月18日在投资者关系平台上答复投资者关心的问题。尽管短期外部环境仍有不确定性，但我们对中国医疗健康产业的发展和中国医疗器械企业国际化发展抱有坚定信心。公司成立十八年来，坚定不移坚持长期主义发展的决心，锚定体外诊断与治疗康复两条核心赛道，以持续的研发投入、一代代的产品积累，扎扎实实地把技术做深、把市场做透、把能力建全。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800030297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644709464","title":"普门科技：股东减持计划系股东基于自身需求作出的自主决策","url":"https://stock-news.laohu8.com/highlight/detail?id=2644709464","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644709464?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:12","pubTimestamp":1781773963,"startTime":"0","endTime":"0","summary":"证券之星消息，普门科技(688389)06月18日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司高管很多都持有股份，如果高管陆续减持，传递着上市即变现的信号，收的是二级市场投资者的菜，如何看待后续高管减持的行为？普门科技回复：尊敬的投资者，您好！股东减持计划系股东基于自身需求作出的自主决策。公司始终重视股东利益，将通过聚焦主业、提升经营质量、提供持续稳定的现金分红回报，为投资者创造长期价值。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800029913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642692524","title":"普门科技：坚持自研内生增长和外延并购扩张相结合的发展路径","url":"https://stock-news.laohu8.com/highlight/detail?id=2642692524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642692524?lang=zh_cn&edition=full","pubTime":"2026-06-09 18:09","pubTimestamp":1780999793,"startTime":"0","endTime":"0","summary":"证券之星消息，普门科技(688389)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问：国家鼓励上市公司并购重组，做大做强。贵公司从2019年上市7年来，在资本市场没有并购重组行为，是否贵公司没有并购重组的专业人才和团队，或贵公司是小公司，没有相应实力和资本、技术。普门科技回复：您好！公司一直坚持自研内生增长和外延并购扩张相结合的发展路径。从过去公司开展的项目投资情况来看，整体进展顺利。未来公司会继续在坚持主业发展的同时，基于现有的技术平台以及市场布局，寻求技术和产品协同性强的细分业务拓展。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900029743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642469271","title":"普门科技：将在8月底前披露2026年半年报","url":"https://stock-news.laohu8.com/highlight/detail?id=2642469271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642469271?lang=zh_cn&edition=full","pubTime":"2026-06-09 18:09","pubTimestamp":1780999770,"startTime":"0","endTime":"0","summary":"证券之星消息，普门科技(688389)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司第二季报什么时候发布普门科技回复：尊敬的投资者，您好！公司将按照上市公司定期报告披露相关规定，在8月底前披露2026年半年报，感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900029735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642646926","title":"普门科技：体外诊断、临床医疗、皮肤医美、消费者健康四大板块业务都具有较大的市场空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2642646926","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642646926?lang=zh_cn&edition=full","pubTime":"2026-06-09 18:09","pubTimestamp":1780999759,"startTime":"0","endTime":"0","summary":"证券之星消息，普门科技(688389)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问：作为一家曾获得国家科学技术奖一等的上市公司，从近几年的研发成果看，实在看不出贵公司产品有何技术壁垒和优势。请贵公司客观公正评价一下贵公司的发展前景。普门科技回复：您好！公司2025年年度报告核心技术与研发进展部分详细介绍了公司的核心技术平台及研发进展的情况。公司体外诊断、临床医疗、皮肤医美、消费者健康四大板块业务都具有较大的市场空间，四大板块的业务规划能够支撑公司未来中长期的业务发展。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900029719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642469254","title":"普门科技：公司会在坚持主业发展的同时，密切关注行业新动态、新技术、新产品的发展方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2642469254","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642469254?lang=zh_cn&edition=full","pubTime":"2026-06-09 18:09","pubTimestamp":1780999759,"startTime":"0","endTime":"0","summary":"证券之星消息，普门科技(688389)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问：有投资者问，贵公司账面存款有12亿，是否有回购计划？我想问：这12亿是否有投资计划，比如投资创新药、脑机接口等前沿科技。普门科技回复：您好！公司会在坚持主业发展的同时，密切关注行业新动态、新技术、新产品的发展方向。如有重大投资事项，会通过定期报告和临时公告进行披露，谢谢！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900029721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642746612","title":"普门科技：暂无跨行转型计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2642746612","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642746612?lang=zh_cn&edition=full","pubTime":"2026-06-09 17:42","pubTimestamp":1780998134,"startTime":"0","endTime":"0","summary":"证券之星消息，普门科技(688389)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问：公司除了医疗器械及试剂外，是否计划向生物医药及创新药方面转型？普门科技回复：尊敬的投资者，您好！公司所处的行业为医疗器械行业，主要从事体外诊断、临床医疗、皮肤医美和消费者健康产品的研发、制造、全球销售和服务，暂无跨行转型计划。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900028834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642466162","title":"普门科技：公司暂无埃博拉病毒相关检测产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2642466162","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642466162?lang=zh_cn&edition=full","pubTime":"2026-06-09 17:42","pubTimestamp":1780998131,"startTime":"0","endTime":"0","summary":"证券之星消息，普门科技(688389)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司是否有埃博拉病毒的检测能力？普门科技回复：您好！公司暂无埃博拉病毒相关检测产品。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900028826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642466169","title":"普门科技：公司与快奥森多的合作项目正常推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2642466169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642466169?lang=zh_cn&edition=full","pubTime":"2026-06-09 17:42","pubTimestamp":1780998124,"startTime":"0","endTime":"0","summary":"证券之星消息，普门科技(688389)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司与奥森多合作最新进展情况如何？有哪些合作成果？产生收益没有？普门科技回复：尊敬的投资者，您好！公司与快奥森多的合作项目正常推进中。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900028816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637375774","title":"每周股票复盘：普门科技（688389）每股派现0.282元（含税）","url":"https://stock-news.laohu8.com/highlight/detail?id=2637375774","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637375774?lang=zh_cn&edition=full","pubTime":"2026-05-24 04:22","pubTimestamp":1779567733,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，普门科技报收于12.25元，较上周的12.47元下跌1.76%。本周，普门科技5月21日盘中最高价报12.66元。普门科技当前最新总市值52.49亿元，在医疗器械板块市值排名71/129，在两市A股市值排名3383/5206。本周关注点公司公告汇总：普门科技2025年年度权益分派实施，每股派发现金红利0.282元（含税）。本次权益分派以公司总股本428,485,730股为基数，共计派发现金红利120,832,975.86元（含税）。分红对象为截至股权登记日在中国结算上海分公司登记在册的全体股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637569337","title":"普门科技（688389）披露2025年年度权益分派实施公告，5月21日股价下跌0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637569337","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637569337?lang=zh_cn&edition=full","pubTime":"2026-05-21 22:49","pubTimestamp":1779374952,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，普门科技报收于12.23元，较前一交易日下跌0.73%，最新总市值为52.4亿元。该股当日开盘12.36元，最高12.66元，最低12.2元，成交额达4663.41万元，换手率为0.87%。近日，普门科技发布《2025年年度权益分派实施公告》，宣布本次权益分派以公司总股本428,485,730股为基数，每股派发现金红利0.282元（含税），不送红股，不进行资本公积转增股本，共计派发现金红利120,832,975.86元（含税）。分红对象为截至股权登记日在中国结算上海分公司登记在册的全体股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100044834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635727661","title":"【私募调研记录】宁波幻方量化调研普门科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2635727661","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635727661?lang=zh_cn&edition=full","pubTime":"2026-05-15 08:01","pubTimestamp":1778803260,"startTime":"0","endTime":"0","summary":"根据市场公开信息及5月14日披露的机构调研信息，知名私募宁波幻方量化近期对1家上市公司进行了调研，相关名单如下：1）普门科技 调研纪要：公司业务涵盖体外诊断、临床医疗、皮肤医美和消费者健康四大板块，均具较大市场空间，支撑中长期发展。2026年一季度海外业务收入同比增长75.87%，预计全年保持稳定增长。聚焦超声皮肤治疗仪已获三类证，市场反馈符合预期。2026年重点推进电化学发光、糖化血红蛋白和医美能量器械业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026051500008396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688389","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635740718","title":"股市必读：普门科技（688389）5月14日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2635740718","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635740718?lang=zh_cn&edition=full","pubTime":"2026-05-15 03:21","pubTimestamp":1778786497,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，普门科技报收于12.59元，下跌2.1%，换手率0.73%，成交量3.14万手，成交额3984.6万元。来自公司公告汇总：普门科技2025年年度股东会审议通过年度报告、利润分配预案等多项议案，表决结果合法有效。公司公告汇总深圳市普门科技股份有限公司于2026年5月13日召开2025年年度股东会，会议由董事会召集，采取现场与网络投票相结合方式举行，出席会议股东及代理人共142名，代表有表决权股份265,738,922股，占公司总表决权股份的62.0181%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500004782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635355117","title":"普门科技（688389）发布2025年年度股东会决议公告，5月13日股价上涨0.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635355117","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635355117?lang=zh_cn&edition=full","pubTime":"2026-05-13 22:43","pubTimestamp":1778683393,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，普门科技报收于12.86元，较前一交易日上涨0.23%，最新总市值为55.1亿元。该股当日开盘12.87元，最高12.88元，最低12.76元，成交额达2388.5万元，换手率为0.43%。近日，深圳普门科技股份有限公司发布《2025年年度股东会决议公告》。公告显示，公司于2026年5月13日召开2025年年度股东会，出席会议股东共142人，代表有表决权股份总数265,738,922股，占公司总表决权股份的62.0181%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300045922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688389"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782100239785,"stockEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.1434},{"period":"3month","weight":-0.1588},{"period":"6month","weight":-0.1881},{"period":"1year","weight":-0.1515},{"period":"ytd","weight":-0.1725}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":-0.019},{"period":"3month","weight":0.0337},{"period":"6month","weight":0.0514},{"period":"1year","weight":0.2071},{"period":"ytd","weight":0.0306}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳普门科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"11295人(较上一季度增加4.45%)","perCapita":"37935股","listingDate":"2019-11-05","address":"广东省深圳市龙华区观湖街道观城社区求知东路8号普门科技总部大厦","registeredCapital":"42848万元","survey":"　　深圳普门科技股份有限公司的主营业务是医疗器械的研发、制造、营销及服务。公司的主要产品是光子治疗仪、红外治疗仪、空气波压力治疗系统、高频振动排痰系统、特定蛋白分析仪、糖化血红蛋白分析仪、电化学发光免疫分析仪、配套检测试剂。普门科技是一家研发智造和市场营销双轮驱动的高科技医疗器械企业、国家高新技术企业、国家级专精特新“小巨人”企业。","listedPrice":9.1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"普门科技(688389)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供普门科技(688389)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"普门科技,688389,普门科技股票,普门科技股票老虎,普门科技股票老虎国际,普门科技行情,普门科技股票行情,普门科技股价,普门科技股市,普门科技股票价格,普门科技股票交易,普门科技股票购买,普门科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"普门科技(688389)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供普门科技(688389)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}